0M0F.L - Tandem Diabetes Care, Inc.

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.97
52-week change 3-61.44%
S&P500 52-week change 31.77%
52-week high 371.18
52-week low 30.00
50-day moving average 338.92
200-day moving average 348.45

Share statistics

Avg vol (3-month) 31.62k
Avg vol (10-day) 3175
Shares outstanding 557.37M
Implied shares outstanding 6N/A
Float 864.21M
% held by insiders 10.54%
% held by institutions 1104.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin -25.64%
Operating margin (ttm)-11.78%

Management effectiveness

Return on assets (ttm)-5.94%
Return on equity (ttm)-52.50%

Income statement

Revenue (ttm)794.69M
Revenue per share (ttm)12.36
Quarterly revenue growth (yoy)-3.70%
Gross profit (ttm)412.99M
EBITDA -79.54M
Net income avi to common (ttm)-203.75M
Diluted EPS (ttm)0.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)519.59M
Total cash per share (mrq)8.04
Total debt (mrq)420.4M
Total debt/equity (mrq)124.10
Current ratio (mrq)4.43
Book value per share (mrq)5.24

Cash flow statement

Operating cash flow (ttm)18.34M
Levered free cash flow (ttm)-33.24M